31 08, 2011

Less than 1 percent of patients participate in oncology trials, why?

By | 2016-10-12T14:35:11+00:00 August 31st, 2011|Categories: News|

A recent paper by W. Al-Refaie et al, in the Annals of Surgery, Vol 254, number 3, Sep 2011 “Cancer Trials versus the Real World in the United States” showed that 0.64% of patients enrolled in clinical trials. Blacks were less likely than whites to enroll in trials (0.48% vs 0.67%, P65 years), early stage cancer, and those with lung or gastrointestinal cancers less likely to be enrolled. Besides some [...]

24 11, 2010

Is Thailand the next hot spot for conducting your clinical trial?

By | 2016-10-12T14:35:11+00:00 November 24th, 2010|Categories: News|

I was having coffee with a colleague the other day and we were discussing international clinic trials and the future of drug development when there seems to be a saturation of trials, investigators and new drug applications in North America. Being a proponent for trials in India, I suggested this country for their patient recruitment in a new oncology product. “India!” he exclaimed, “you know what that stands for don’t [...]

Load More Posts